WithdrawnNCT00534898
Bexarotene and Fenretinide as Addition to Antipsychotic Treatment in Schizophrenia Patients
This study evaluates the effectiveness of Bexarotene for people with schizophrenia.
Medication studyAges 18–60Israel
Understand this study
What is this study about?
This study evaluates the effectiveness of Bexarotene for people with schizophrenia.
Who could participate?
This study is for people with schizophrenia. Listed age limits: 18 years to 60 years. Other eligibility criteria apply.
- Listed locations
- Be'er Sheva, HaderaSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateNot clearly listed
- Recruitment status
- Withdrawn
- Enrollment listed in the registry
- Not clearly listed
- Sponsor
- Beersheva Mental Health Center
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- Israel
- Age range
- From 18 Years to 60 Years
- Official registry ID
- NCT00534898
- Official title
Show the full official title
Comparison Efficacy of Bexarotene and Fenretinide as Addition to Antipsychotic Treatment in Schizophrenia Patients: Double-blind Placebo Controlled Study
Recruitment & locations
WithdrawnThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Be'er Sheva, Hadera
Interested in joining this study?
Questions about this study
What is this study about?
This study evaluates the effectiveness of Bexarotene for people with schizophrenia.
Who is behind this study?
The study sponsor is Beersheva Mental Health Center, a hospital or academic medical center.
Does this study involve medication?
Yes. The study involves medication, including Bexarotene, Fenretinide and Placebo.
Who can participate?
This study is for people with schizophrenia. Listed age limits: 18 years to 60 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as withdrawn.
